Evidence map›Paper›PMID 40131835›Full record

ReviewBiochemical Society transactions2025

Chlamydia trachomatis invasion: a duet of effectors.

Tyler J Zimmerman, Rey A Carabeo

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tyler J ZimmermanDepartment of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska 68198, U.S.A.
Rey A CarabeoDepartment of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska 68198, U.S.A.ORCID 0000-0002-5708-5493

Funding

CHLAMYDIAL INVASION OF NON-PHAGOCYTIC CELLSR01AI065545 · NIAID · WASHINGTON STATE UNIVERSITY · PI CARABEO, REY A · 2005 to 2021
$3.3M
NIAID NIH HHS R01 AI065545
6 · The paper itself

Abstract

Members of the genus Chlamydia require an intracellular niche for growth and replication, thus highlighting the extreme significance of its ability to invade epithelial cells-the favored host cell in vivo. Because epithelial cells are not phagocytic, the uptake of Chlamydia must be driven by the pathogen. To this end, two bacterial proteins, translocated actin-recruiting protein (TarP) and translocated membrane effector A (TmeA), identified in Chlamydia trachomatis are translocated from the infectious chlamydial elementary bodies to the host cell cytosol to facilitate extensive remodeling of the cortical actin network to produce protrusive structures designed for pathogen engulfment. Notably, both effectors act by promoting highly localized actin nucleation at sites of bacterial adhesion. However, they have non-redundant functions, with both required for optimal actin remodeling dynamics and efficient invasion. Finally, these effectors also mediate the latter stages of the invasion process, specifically by modulating host dynamin 2, a large GTPase critical to closure and scission of invaginating vesicles harboring elementary bodies. In summary, TarP and TmeA orchestrate major aspects of C. trachomatis invasion.

Indexed as

Bacterial ProteinsChlamydia InfectionsChlamydia trachomatisActinsAnimalsEpithelial CellsHost-Pathogen InteractionsHumansActinsBacterial ProteinsActin DynamicsChlamydia trachomatisInvasionType III Effector

Identifiers

PMID40131835
PMCPMC12203932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.